|

WHO: Pause in AstraZeneca's COVID-19 vaccine trial shows it is well-run

“The pause in AstraZeneca's COVID-19 vaccine trial shows it is a 'well-run' trial,” World Health Organisation (WHO) said in a statement on Tuesday.

The WHO, further, said that the pause showed that they have looked at safety in 'an appropriate manner'.

Last week, AstraZeneca and the University of Oxford announced that they had stopped the key phase 3 trials of a coronavirus vaccine after a participant was found to have an inflammatory syndrome that affects the spinal cord.

Over the weekend, the British pharma company said that they have been given a go-ahead to restart the vaccine trials in the UK.

Market reaction

The market mood is already upbeat and therefore the comments from WHO add to the optimism. 

AstraZeneca plc is gaining 2.50% to regain 8,600 levels, at the time of writing.

S&P 500 futures rally 0.68%, approaching the 3,400 mark. AUD/USD trades close to weekly tops of 0.7336, up 0.51% on the day.

Author

Dhwani Mehta

Dhwani Mehta

FXStreet

Residing in Mumbai (India), Dhwani is a Senior Analyst and Manager of the Asian session at FXStreet. She has over 10 years of experience in analyzing and covering the global financial markets, with specialization in Forex and commodities markets.

More from Dhwani Mehta
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD posts modest gains above 1.1700 as ECB signals pause

The EUR/USD pair posts modest gains around 1.1710 during the early Asian session on Monday. The Euro strengthens against the Greenback after the European Central Bank left its policy rates unchanged and took a more positive view on the Eurozone economy, which has shown resilience to global trade shocks. Financial markets are likely to remain subdued as traders book profits ahead of the long holiday period.

GBP/USD gains ground near 1.3400 ahead of UK Q3 GDP data

GBP/USD gains ground after three days of losses, trading around 1.3390 during the Asian hours on Monday. The pair depreciates as the Pound Sterling holds ground ahead of the release of the United Kingdom Gross Domestic Product for the third quarter.

Gold refreshes record highs, eyes $4,400 amid renewed geopolitical tensions

Gold is closing in on $4,400 early Monday, renewing lifetime highs, helped by renewed geopolitical tensions. Israel-Iran conflict and US-Venezuela headlines drive investors toward the traditional store of value, Gold. 

Week ahead: Key risks to watch in last days of 2025 and early 2026

The festive period officially starts next week, with many traders vacating their desks until the first full week of January, making way for thin trading volumes and very few top-tier releases.

De-dollarisation by design: Gold’s partner in the new system

You don’t need another 2008 for the system to reset. You just need enough nations to stop settling trade in dollars. And that’s already happening. "If gold is the anchor, what actually moves value in a post-dollar world?” It’s a question most gold investors overlook. We think in terms of storage and preservation, but in the new rails being built, settlement speed matters just as much as soundness of money.

XRP rebounds amid ETF inflows and declining retail demand demand

XRP rebounds as bulls target a short-term breakout above $2.00 on Friday. XRP ETFs record the highest inflow since December 8, signaling growing institutional appetite.